CCMG
ELV icon

Clark Capital Management Group’s Elevance Health ELV Stock Holding History

Clark Capital Management Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Sell
806
-38
-5% -$12.5K ﹤0.01% 486
2025
Q4 		$296K Buy
844
+130
+18% +$43.9K ﹤0.01% 430
2025
Q3 		$231K Sell
714
-27
-4% -$8.4K ﹤0.01% 424
2025
Q2 		$288K Buy
741
+14
+2% +$5.63K ﹤0.01% 377
2025
Q1 		$316K Sell
727
-12,363
-94% -$4.96M ﹤0.01% 372
2024
Q4 		$4.83M Sell
13,090
-197,923
-94% -$82.8M 0.03% 196
2024
Q3 		$110M Buy
211,013
+123,638
+142% +$66.1M 0.75% 32
2024
Q2 		$47.3M Buy
87,375
+21,075
+32% +$11.1M 0.35% 82
2024
Q1 		$34.4M Sell
66,300
-17,924
-21% -$8.91M 0.26% 129
2023
Q4 		$39.7M Sell
84,224
-1,121
-1% -$518K 0.33% 96
2023
Q3 		$37.2M Buy
85,345
+1,519
+2% +$689K 0.37% 84
2023
Q2 		$37.2M Buy
83,826
+3,569
+4% +$1.65M 0.33% 87
2023
Q1 		$36.9M Buy
80,257
+25,143
+46% +$12M 0.41% 74
2022
Q4 		$28.3M Buy
55,114
+11,095
+25% +$5.63M 0.26% 114
2022
Q3 		$20M Buy
44,019
+2,167
+5% +$1.04M 0.26% 138
2022
Q2 		$20.2M Buy
41,852
+41,378
+8,730% +$20.5M 0.27% 129
2022
Q1 		$233K Sell
474
-48
-9% -$21.9K ﹤0.01% 349
2021
Q4 		$242K Buy
+522
New +$220K ﹤0.01% 339
2020
Q3 		– Sell
-71,282
Closed -$18.7M – 314
2020
Q2 		$18.7M Buy
71,282
+2,262
+3% +$603K 0.35% 116
2020
Q1 		$15.7M Buy
69,020
+1,285
+2% +$350K 0.4% 100
2019
Q4 		$20.5M Buy
67,735
+16
+0% +$4.4K 0.43% 96
2019
Q3 		$16.3M Sell
67,719
-1,248
-2% -$342K 0.37% 114
2019
Q2 		$19.5M Buy
+68,967
New +$18.8M 0.41% 93
2016
Q4 		– Sell
-32,584
Closed -$4.08M – 298
2016
Q3 		$4.08M Sell
32,584
-6,722
-17% -$868K 0.23% 129
2016
Q2 		$5.16M Buy
39,306
+21,525
+121% +$2.95M 0.33% 87
2016
Q1 		$2.47M Buy
17,781
+2,434
+16% +$325K 0.19% 125
2015
Q4 		$2.14M Sell
15,347
-33,239
-68% -$4.58M 0.17% 130
2015
Q3 		$6.8M Sell
48,586
-60,496
-55% -$9.09M 0.61% 52
2015
Q2 		$17.9M Buy
109,082
+252
+0.2% +$40.3K 1.64% 7
2015
Q1 		$16.8M Sell
108,830
-10
-0% -$1.42K 1.53% 10
2014
Q4 		$13.7M Buy
108,840
+626
+0.6% +$77.4K 1.25% 13
2014
Q3 		$12.9M Buy
108,214
+16,248
+18% +$1.86M 1.12% 14
2014
Q2 		$9.9M Buy
91,966
+29,775
+48% +$3.07M 0.82% 28
2014
Q1 		$6.19M Buy
62,191
+3,194
+5% +$289K 0.53% 60
2013
Q4 		$5.45M Buy
58,997
+6,236
+12% +$554K 0.45% 66
2013
Q3 		$4.41M Buy
+52,761
New +$4.52M 0.35% 67

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Clark Capital Management Group's ELV Position: Q1 2026 in Review

Clark Capital Management Group reduced its Elevance Health (ELV) stake by 4.5% in Q1 2026, selling an estimated $12.5K and leaving 806 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #486.

Clark Capital Management Group first reported a position in ELV in Q3 2013 and has held it in 36 quarters since. The position peaked at $110M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Clark Capital Management Group held 806 shares of Elevance Health worth $236K as of Q1 2026.
  • Clark Capital Management Group sold 38 Elevance Health shares in Q1 2026, an estimated $12.5K.
  • Elevance Health made up ﹤0.01% of Clark Capital Management Group's portfolio in Q1 2026, its #486 holding.
  • Clark Capital Management Group first reported a position in Elevance Health in Q3 2013 and has held it in 36 quarters since.
  • Clark Capital Management Group's Elevance Health position peaked at $110M in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.